Comparison in Need for Bank Blood Between Patients Undergoing Total Hip Surgery That Either Receive Their Own Blood Back or Not

Inclusion criteria

• Provision of informed consent
• Scheduled for primary or secondary, cemented or non-cemented, total hip arthroplasty
• Classified as ASA Physical Status Classification System class P1, P2 or P3 according to the American Society of Anaesthesiology.

Exclusion criteria

• Involvement in the planning and conduct of the study (applies to both Astra Tech staff or staff at the study site)
• Previous enrollment or randomisation of treatment in the present study
• Expected or confirmed participation in another clinical study, that may interfere with the present study, during the study period
• Suspected severe non-compliance to protocol as judged by the investigator
• Current symptoms of haemophilia
• Current symptoms of hyperkalaemia
• Current symptoms of systemic infection or local infection in the operation field
• Current symptoms of impaired renal function including creatinine/clearance levels above the normal reference values
• History of or presence of malignant disease with propensity for systemic spread during the last 5 years
• Current or expected use of cytotoxic drugs
• Current untreated anaemia (e.g. sickle cell anaemia), i.e. Hb concentration < 11 g/dl (7 mmol/l)
• Use of recombinant erythopoetin
• Use of aprotinin and/or fibrin sealant
• Use of other autologous blood transfusion than that with the Sangvia® system (e.g. CellSaver, pre-donation, acute normovolemic haemodilution etc.)
• Women of childbearing age
• Fractures
• Revision/secondary total hip surgery with expected serious bone grafting